KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Acadia Pharmaceuticals (ACAD) Other Non Operating Income: 2018-2025

Historic Other Non Operating Income for Acadia Pharmaceuticals (ACAD) over the last 7 years, with Sep 2025 value amounting to $593,000.

  • Acadia Pharmaceuticals' Other Non Operating Income rose 2.95% to $593,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year decrease of 14.73%. This contributed to the annual value of $1.8 million for FY2024, which is 64.32% down from last year.
  • Latest data reveals that Acadia Pharmaceuticals reported Other Non Operating Income of $593,000 as of Q3 2025, which was down 0.17% from $594,000 recorded in Q2 2025.
  • Acadia Pharmaceuticals' 5-year Other Non Operating Income high stood at $4.8 million for Q1 2023, and its period low was -$1.2 million during Q2 2023.
  • Moreover, its 3-year median value for Other Non Operating Income was $582,000 (2024), whereas its average is $870,700.
  • In the last 5 years, Acadia Pharmaceuticals' Other Non Operating Income plummeted by 379.21% in 2022 and then soared by 1,325.00% in 2023.
  • Acadia Pharmaceuticals' Other Non Operating Income (Quarterly) stood at $1.6 million in 2021, then decreased by 4.93% to $1.5 million in 2022, then slumped by 30.06% to $1.5 million in 2023, then slumped by 61.80% to $575,000 in 2024, then grew by 2.95% to $593,000 in 2025.
  • Its Other Non Operating Income was $593,000 in Q3 2025, compared to $594,000 in Q2 2025 and $588,000 in Q1 2025.